First Report of Nocardia farcinica Bursitis in a Patient with Diabetes Mellitus

Soon-Deok PARK; Han-Jun KIM; In-Ho JANG; Young UH; Juwon KIM; Kap-Joon YOON; Jin-Rok OH.
Annals of Laboratory Medicine ; : 252-255, 2014.
Artículo en Inglés | WPRIM | ID: wpr-126212

Documentos relacionados

  1. A Rare Cause of Coagulopathy in the Emergency Department: Cefoperazone Use.
  2. In vitro activity of eravacycline and cefoperazone/ sulbactam against extensively-drug resistant and pan-drug resistant Acinetobacter baumannii isolates from a tertiary hospital in Greece.
  3. Observation of clinical efficacy of the cefoperazone/sulbactam anti-infective regimen in the treatment of multidrug-resistant Acinetobacter baumannii lung infection.
  4. A case of <i>Elizabethkingia meningoseptica</i> septicemia.
  5. Role of the gut microbiota in cefoperazone/sulbactam-induced epilepsy in mice with chronic renal failure.
  6. P1-6: Clinical effectiveness of cefoperazone-sulbactam versus piperacillin-tazobactam for the treatment of pneumonia in the elderly population.
  7. Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response.
  8. Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
  9. Pharmacokinetic and pharmacodynamic analysis of cefoperazone/sulbactam for the treatment of pediatric sepsis by Monte Carlo simulation.
  10. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.